Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients.
Jacquin JP, Chargari C, Thorin J, Mille D, Mélis A, Orfeuvre H, Clavreul G, Chaigneau L, Nourissat A, Dumanoir C, Savary J, Merrouche Y, Magné N.
Jacquin JP, et al. Among authors: chargari c.
Am J Clin Oncol. 2012 Feb;35(1):18-21. doi: 10.1097/COC.0b013e3182005783.
Am J Clin Oncol. 2012.
PMID: 21278560
Clinical Trial.